Pamela is a director with Kalypso, focusing on PLM, portfolio management and strategy work.
Pamela serves clients in the life sciences, discrete, high tech and CPG industries.
Complete the form below and we'll be in touch with you shortly.
Required fields are marked with an asterisk (*).
Prior to joining Kalypso, Pamela worked with Ingersoll-Rand Company in their industrial technologies business, both during college and after graduation as a process improvement engineer. She mainly focused on driving the lean manufacturing initiatives at a plant, as well as within the entire business. She was responsible for training management, supervisors, and the factory floor. She led Kaizen projects that generated substantial operational savings, as well as removing non-value activity from the operations. She also developed database programs to monitor factory metrics.
Pamela graduated from North Carolina State University in 2003 with a Bachelor of Science in Industrial Engineering. A noteworthy accomplishment from her school days was leading the winning Industrial Engineering Senior Design project team in their senior class competition.
Since joining Kalypso, Pamela has served clients in the medical device, discrete, high tech and CPG industries. Her main expertise is in project portfolio management design and implementation for telecom, specialty chemical, biotech, and healthcare. Her other areas of expertise include strategic roadmapping, resource management, IP commercialization, PLM & product data management, and lean manufacturing. She has to say about Kalypso, "I am very excited to be working with a firm with so many different intellectual backgrounds. The management of the firm really cares about our clients and what is important to them. Kalypso definitely will do whatever it takes to make all projects a success."
Pamela enjoys traveling, especially internationally. Her biggest hobby is studying and monitoring designer fashion. She also enjoys comical writing and hopes one day she will finish her novel, have it published, and it will hit #1 on the New York Times Bestseller List.